HODGKIN'S DISEASE IN BRAZIL: TRENDS IN HOSPITALIZATIONS, DEATHS, AND HOSPITAL COSTS FROM 2018 TO 2024

Resumen

Introduction: Hodgkin's disease is a malignant neoplasm of the lymphatic system, with a higher incidence in adolescents and young adults. With a high potential for cure, its efficient management depends on early diagnosis and targeted public policies. This study analyzed the profile of hospital admissions for Hodgkin's disease in Brazil, between 2018 and 2024, considering clinical, sociodemographic, and economic variables. Methodology: Descriptive and quantitative study, with secondary data obtained from DATASUS/TabNet. Hospital admissions due to Hodgkin's disease (ICD-10: C81) were analyzed, considering year, sex, age group, race/color, nature of care (urgent or elective), hospital deaths, and financial values (average cost per hospitalization and annual total). Results: A total of 37,367 hospitalizations were recorded in the period, with a higher concentration among patients aged 10 to 29 years (49.4%) and a predominance of males (55.59%). Emergency hospitalizations accounted for 55.61% of the total, suggesting a delay in diagnosis. Brown (42.44%) and white (42.29%) were the most affected racial groups. The peak of deaths occurred in 2023 (216), and the lowest number in 2020 (165). The average cost per hospitalization ranged between R$ 2,472.09 and R$ 2,878.80, with a progressive increase in total hospital expenses, reaching R$ 13.26 million in 2024. Conclusion: Hodgkin's disease in Brazil maintains its classic pattern of incidence, with a predominance in young men. The high proportion of hospitalizations due to urgency and the increase in hospital costs reinforce the need for strategies for early diagnosis, rationalization of resources, and strengthening of cancer care in the SUS.